These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1767350)

  • 21. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy.
    Mizokami Y; Narushima K; Shiraishi T; Otsubo T; Narasaka T; Matsuoka T
    J Gastroenterol; 2000; 35 Suppl 12():38-41. PubMed ID: 10779216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
    Karateev AE; Nasonov EL; Radenska-Lopovok SG
    Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New drug to prevent NSAID-related ulcers.
    Liss GM
    CMAJ; 1996 Oct; 155(8):1043. PubMed ID: 8873631
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacoeconomic aspects of non-steroidal anti-inflammatory drug gastropathy.
    Walan A; Wahlqvist P
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S79-88. PubMed ID: 10379474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ranitidine effect on gastric mucosa damage in patients with rheumatoid diseases on long-term treatment with non-steroid anti-inflammatory drugs.
    Piotrowski J; Gabryelewicz A; Konturek S; Kwiecień N; Rydzewska G; Sierakowski S; Zimnoch L
    Mater Med Pol; 1986; 18(3):170-6. PubMed ID: 3807434
    [No Abstract]   [Full Text] [Related]  

  • 30. [De-nol in NSAID-induced gastroduodenal lesions].
    Cataldo MG; D'Aiuto A; Bongiorno A
    Minerva Dietol Gastroenterol; 1990; 36(1):27-30. PubMed ID: 2186304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
    Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating ulcers in patients receiving anti-arthritic drugs.
    Langman MJ
    Q J Med; 1989 Dec; 73(272):1089-91. PubMed ID: 2575773
    [No Abstract]   [Full Text] [Related]  

  • 33. Misoprostol (Cytotec) in NSAID gastropathy.
    Habibullah CM; Singh SP; Phaterpekar SJ
    J Assoc Physicians India; 1993 Nov; 41(11):770. PubMed ID: 8005958
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs.
    Agrawal NM; Aziz K
    J Rheumatol Suppl; 1998 May; 51():17-20. PubMed ID: 9596550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
    Chiba T; Sato K; Endo M; Ando T; Inomata M; Orii S; Suzuki K
    Hepatogastroenterology; 2005; 52(64):1134-8. PubMed ID: 16001646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fixed-dose combination ibuprofen and famotidine (Duexis).
    Med Lett Drugs Ther; 2011 Oct; 53(1376):85-6. PubMed ID: 22033211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranitidine and non-steroidal anti-inflammatory drug (NSAID) associated gastric and duodenal ulcers.
    Bank S; Greenberg RE; Zucker S
    Gut; 1991 Aug; 32(8):963-4. PubMed ID: 1885083
    [No Abstract]   [Full Text] [Related]  

  • 40. Diclofenac/misoprostol: the European clinical experience.
    McKenna F
    J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.